Physician profile
Christee E Bond
NPI 1598231789
$9,697.28
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,112 · 2022: $3,725 · 2023: $3,391 · 2024: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,860.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,860.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,693.67 | 2021-2024 | Trelegy Ellipta, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $1,401.73 | 2021-2024 | Glassia |
| Astrazeneca Pharmaceuticals LP | $1,036.21 | 2021-2024 | Tezspire, Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $546.83 | 2021-2024 | Ofev |
| Mylan Specialty L.P. | $504.91 | 2021-2023 | Yupelri |
| Harmony Biosciences LLC | $501.76 | 2022-2023 | Wakix |
| Regeneron Healthcare Solutions, INC. | $483.98 | 2021-2024 | Dupixent |
| Grifols USA, LLC | $439.91 | 2021-2024 | Prolastin-C Liquid |
| Jazz Pharmaceuticals INC. | $371.69 | 2021-2023 | |
| Genzyme Corporation | $353.10 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $300.04 | 2021-2023 | Acthar |
| Amgen INC. | $259.50 | 2022-2024 | Tezspire |
| Eisai INC. | $184.45 | 2021-2022 | |
| Insmed, INC. | $157.02 | 2021-2023 | Arikayce |
| Bayer Healthcare Pharmaceuticals INC. | $144.37 | 2022-2023 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $142.66 | 2022 | |
| Inogen, INC. | $124.20 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Electromed, INC. | $120.78 | 2021-2023 | Smartvest |
| Ani Pharmaceuticals, INC. | $94.10 | 2023-2024 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $92.61 | 2021-2024 | Tyvaso |
| Idorsia Pharmaceuticals US INC | $86.94 | 2022-2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $78.17 | 2022-2023 | |
| Arbor Pharmaceuticals, INC. | $75.65 | 2021-2022 | |
| Covis Pharma Gmbh | $70.67 | 2022 | |
| Abbvie INC. | $47.96 | 2024 | |
| Genentech USA, INC. | $46.19 | 2022-2023 | Xolair |
| Merck Sharp & Dohme LLC | $39.57 | 2022-2023 | |
| Almatica Pharma LLC | $38.41 | 2021 | |
| Vapotherm INC | $32.00 | 2022 | |
| Pfizer INC. | $31.77 | 2022-2023 | |
| Pharming Healthcare, INC. | $21.93 | 2022 | |
| Azurity Pharmaceuticals, INC. | $20.48 | 2023 | Horizant |
| Sunovion Pharmaceuticals INC. | $20.00 | 2021 | |
| Axsome Therapeutics, INC. | $19.39 | 2023 | Sunosi |
| Novartis Pharmaceuticals Corporation | $18.43 | 2023 | |
| Phadia US INC. | $18.26 | 2021 | |
| Shield Therapeutics INC | $16.57 | 2023 | Accrufer |
| Pulmonx Corporation | $16.44 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Shionogi INC | $15.45 | 2021 | |
| Tactile Systems Technology INC | $14.74 | 2023 | Flexitouch Plus, Entre Plus |
| Paratek Pharmaceuticals, INC. | $14.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christee Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.